Middle East & Africa Synthetic Biology Market Size & Outlook

The synthetic biology market in Middle East & Africa is expected to reach a projected revenue of US$ 1,023.6 million by 2033. A compound annual growth rate of 14% is expected of Middle East & Africa synthetic biology market from 2026 to 2033.
Revenue, 2025 (US$M)
$360.7
Forecast, 2033 (US$M)
$1,023.6
CAGR, 2026 - 2033
14%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa synthetic biology market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA synthetic biology market highlights

  • The MEA synthetic biology market generated a revenue of USD 360.7 million in 2025.
  • The market is expected to grow at a CAGR of 14% from 2026 to 2033.
  • In terms of segment, pcr technology was the largest revenue generating technology in 2025.
  • PCR Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Saudi Arabia is expected to register the highest CAGR from 2026 to 2033.


MEA data book summary

Market revenue in 2025USD 360.7 million
Market revenue in 2033USD 1,023.6 million
Growth rate14% (CAGR from 2026 to 2033)
Largest segmentPcr technology
Fastest growing segmentPCR Technology
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPCR Technology, Genome Editing Technology, NGS Technology, Bioprocessing Technology, Other Technologies
Key market players worldwideBasf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, MEA region accounted for 1.9% of the global synthetic biology market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 18,684.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Synthetic Biology Market Companies

Name Profile # Employees HQ Website
Novozymes View profile 5001-10000 Bagsværd, Hovedstaden, Denmark, Europe https://www.novozymes.com/en#
Synthego View profile 251-500 Redwood City, California, United States, North America http://www.synthego.com
Codexis Inc View profile 174 200 Penobscot Drive, Redwood, CA, United States, 94063 https://www.codexis.com
DNAstar View profile 51-100 Madison, Wisconsin, United States, North America http://www.dnastar.com
New England Biolabs View profile 501-1000 Ipswich, Massachusetts, United States, North America http://neb.com
Eurofins Scientific SE View profile 61798 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 https://www.eurofins.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Basf SE View profile 111855 Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 https://www.basf.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Middle East & Africa synthetic biology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.


Pcr technology was the largest segment with a revenue share of 34.49% in 2025. Horizon Databook has segmented the Middle East & Africa synthetic biology market based on pcr technology, genome editing technology, ngs technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2021 to 2033.


Increasing demand for alternative fuels, such as biofuels, and rising popularity for protein therapeutics are among factors expected to propel market growth in the region. In addition, rising demand for genetically modified crops and significant technological advancements in DNA studies are expected to drive market growth.

For instance, South Africa has a well-established plant biotechnology community and broad legislative framework to regulate utilization of local botanic resources and genetically modified organisms. In South Africa, plant-made therapeutics are well-developed in the form of utilization of natural plant diversity.

Reasons to subscribe to Middle East & Africa synthetic biology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa synthetic biology market databook

  • Our clientele includes a mix of synthetic biology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa synthetic biology market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa synthetic biology market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA synthetic biology market size, by country, 2021-2033 (US$M)

Middle East & Africa Synthetic Biology Market Outlook Share, 2025 & 2033 (US$M)

MEA synthetic biology market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online